Page 595 - 先天性心脏病的导管术：从婴幼儿期到成人期

45 新型自膨胀肺动脉瓣和装置 577

45.7 结论

在过去的 20 年里，ToF 外科修复术后肺返流的治疗方法不断发展。直到最近，
只有约 25% 的患者适合经导管瓣膜植入术。随着技术的进一步发展，未来十年内大
多数患者或许可以通过经导管瓣膜植入技术进行治疗。随着专为更大的、非导管、流

出道设计的新型瓣膜的出现，可以选择经导管瓣膜治疗的患者数量会不断增加。然而，
这些瓣膜目前都处于不同的临床试验阶段，能否实现商业化转化仍有待观察。

参考文献

[1] Babu-Narayan SV, Diller GP, Gheta RR, et al. Clinical outcomes of surgical pulmonary

valve replacement after repair of tetralogy of Fallot and potential prognostic value of
preoperative cardiopulmonary exercise testing. Circulation. 2014;129(1):18-27.
[2] Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary

valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.
Lancet. 2000;356:1403-5.
[3] Momenah TS, El-Oakley R, Al-Najashi K, et al. Extended application of percutaneous
pulmonary valve implantation. J Am Coll Cardiol. 2009;53:1859-63.
[4] Ansari MM, Cardoso R, Garcia D, et al. Percutaneous pulmonary valve implantation,

present status and evolving future. J Am Coll Cardiol. 2015;66:2246-55.
[5] Jones MI, Qureshi SA. Recent advances in transcatheter management of pulmonary re-
gurgitation after surgical repair of tetralogy of Fallot. F1000. Research. 2018;7:679.

[6] Cao QL, Kenny D, Zhou D, et al. Early clinical experience with a novel self-expanding
percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardio-
vasc Interv. 2014;84:1131-7.
[7] Promphan W, Prachasilchai P, Siripornpitak S, et al. Percutaneous pulmonary valve im-
plantation with the Venus P-valve: clinical experience and early results. Cardiol Young.

2016;26(4):698-710.
[8] Morgan G, Prachasilchai P, Promphan W, et al. Medium-term results of percutaneous
pulmonary valve implantation using the Venus P-valve: international experience. Euro-

Intervention. 2019;14:1363-70.
[9] Zhou D, Pan W, Jilaihawi H, et al. A self-expanding percutaneous valve for patients
with pulmonary regurgitation and an enlarged native right ventricular outflow tract: one-